A Study On The Waste Management Strategies Of Glaxosmithkline (gsk) Nigeria Plc

This study was undertaken to identify and evaluate the waste reduction management strategies in Glaxo Simithline (GSK) Nigeria Plc, Lagos.  In generating total need to achieve the objective of the study, the researcher consulted many textbook, journals, periodicals and paper work. These were renewed and deductions and additions were made appropriately. The study was also conducted by using primary and secondary sources of data collection as well as percentage and made in the data analysis and interpretation.  Based on the analysis of data some findings include that good waste reduction management strategies exist and these include but not limited to processes improvement strategies emphasis on efficiency maintenance of plants/equipment and employing qualified trained personnel.  Therefore, this work suggest that the company should intensify, efforts towards achieving zero waste through establishment of secondary application for all waster generated. 

Title page         ii

Approval page         iii

Dedication         iv

Acknowledgement        v

Abstract          x

Table of Contents        xi

 

CHAPTER ONE

1.0 Introduction         1

1.1 Background of the study       1

1.2 Statement of the problem      6

1.3 Objective of the study       7

1.4 Research Question        8

1.5 Research Hypothesis       9

1.6 Significance of the Study      10

1.7 Scope of the Study        11

1.8 Limitation of the study       12

1.9 Definition of terms        13

References

CHAPTER TWO 

2.1 Literature of Related Review      18

2.2 Waste Prevention Models      21

2.3 Waste Disposal Techniques       28

2.4 Waste minimization strategies     45

2.5 Case studies on Waste Minimization    50

2.6 Basel convention on Waste Management   52

2.7 Overview of facility- Glaxo smithline Nigeria Plc 53  

2.8 Existing Waste Management strategies by (GSK)  53

 References 

 

CHAPTER THREE 

Research Methodology 

3.0 Introduction         58

3.1 Source of Data        59

3.2 Study Population        59

3.3 Sampling size Determination      60

3.4 Sampling Procedure       63 

3.5 Data Collection Instrument      64 

3.6 Method of Data Analysis       67

3.7 Decision Rule         70 

3.8  Validity and Reliability of Instrument   71 

 References 

CHAPTER FOUR 

4.0 Data Presentation and Analysis     73

4.1 Presentation and Analysis of Data    73 

4.2 Hypothesis Testing       78

4.3 Summary of Result       87    

CHAPTER FIVE 

Summary of Findings, Conclusion and Recommendation 

5.1 Summary of Findings       88

5.2 Conclusion         90

5.3 Recommendation        93

 Bibliography 

 Appendix 

Glaxo Smithkline (GSK) Nigeria Plc, is a corporate organization, which was incorporated in Nigeria as a public limited liability company in 1971. Currently it has tow factories located in Agbara and Ilupeju, GS is quoted on the Nigeria stock market and is positioned to be the leading pharmaceutical company in Nigeria GS line of product include 

A.  Analgesics; Panadol, Panadol Extra, Cotenol, Phensix and Phensicplus. 

B. Nutritional drinks: Lucozads, lucozade boest etc 

C. Multivitamin tonic: Extravite 

D. Laxatives: Andrews liver salt. 

E. Oral care: Macleans 

The analgesics, multivitamin tonic and laxatives are manufactured at the Ilupeju factory, while the Agbara orsal care is under contract manufacture with UACP and PP as an embodiment of it’s valves GS integrates environment and safety into the very fabric of the business to benefit her various customers and to achieve: 

- Compliance with all applicable laws, regulations legislation and GS environment and safety  standards 

- A work culture that promotes a safe work place characterized by absence of occupation injures and illnesses. 

- Safe and environmentally responsible development and manufacture of her products.       

- Protection of the environment through the optimal utilization of resources and prevention of any adverse impact on the environment and the global community. 

- Worldwide leadership in the industry with a superior environment and safety vision: the foundation of a environment and safety programmes is set out in policy statement, which commits  GS to 

- Improve efficiency and reduce waste 

- Maximize the efficient use of energy. 

- Design packaging to minimize resources uses and maximize recycling capabilities. 

- Operate responsibility and cooperatively with the community (Hagan, 2000).  

There also, exist standards, covering emissions to air and water, waste disposal and energy  usage in GSK Nigeria Plc generally, there exist following requirements: 

- Identification and classification of waste 

- Waste generation rates 

- Segregation and storage of waste 

- Identification and selection of waste recycling, recovery storage and disposal options 

- Transportation of waste 

- Waste disposal contractor management 

- Documentation and record keeping 

- Management of waste produced by contractors working for GSk 

All manufacturing process are usually accomplained with by waste generation. In GSK sources of waste include the various raw and packaging materials, chemical and chemical products, intermediate and finished products,  metal scraps, sand, spent grease oil, gaseous emissions/fumes petrochemical and domestic wastes. 

 These  waste are commonly categorized into three forms viz solid waste, liquid/effluent waste, and sem-solid (paste form) waste. 

These forms of waste could be hazardous or non-hazardous. The hazardous waste include: 

a) Waste solvents – eg tablets/powers/liquid/or pastes destroyed by soaking and diluting with water, manufacturing floor washings, mopped up spill etc

- All waste laboratory chemicals-resulting from analysis expired chemical etc 

- Use of asbestos and metals (equipment scrape/spare parts)       

The non-hazardous waste include but not limited in packaging waste paper, plastic, food. 

 Waste management including strategies has been a global  concern and its effect on environment is currently top on international agenda. To this effect GSK budget and spends an average of N2.5 million on waste management annually.